FinancialBuzz.com’s latest Behind the Buzz Show: Featuring Our Corporate Overview on Numinus Wellness Inc.
Chairman & CEO Payton Nyquvest
Former Director, VP and Head of Sales at Mackie Research Capital, one of Canada’s largest independent brokerage firms with a focus on public health and human advancement. Fifteen years experience in investment banking, has raised over $100 million for 100+ public and private companies. Former investment advisor with Jordan Capital Markets, Canaccord Financial.
Numinus is a Vancouver-based health care company helping to support the universal desire to heal and be well. Numinus believes the societal costs of mental illness, addictions, trauma and unmet human potential are much too high. New approaches and new ways of thinking are required to supplement existing options, including the application of psychedelic assisted therapies when approved by regulators. Numinus Wellness operates a stand-alone centre offering patients integrative health solutions to help heal, connect and grow. Psychedelic assisted therapies will be part of this offering but will only be available for treatment once approved by regulators and governing bodies — a process Numinus is helping to support. Numinus R&D is creating partnerships with leading research groups to advance practice and understanding in the space. Numinus Bioscience is licensed by Health Canada to test, sell, distribute, and eventually conduct research on psychedelic substances. Sustainable cannabis revenue driven by testing operations provides us a foundation for growth.
For more information, please visit: Numinus Wellness Inc.
For more corporate news on Numinus Wellness Inc., check out the Buzz on the Street
About Behind the Buzz: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Behind the Buzz looks to become a leader in corporate video news dissemination. Behind the Buzz is 100% original content, brought to you by Financial Buzz Media.